Abstract
A continuing, massive, global epidemic of folic acidpreventable spina bifida and anencephaly affects more than 200,000 children and their families each year (Botto et al., 1999). This unnecessary epidemic is the result of a tragic failure of global public policy. Health and food authorities around the world have either not required any folic acid fortification programs (as in Europe, Australia, and New Zealand), or they have implemented fortification programs that do not require enough folic acid to be added to flour (as in the United States and Canada). The article by De Wals and colleagues in this issue of the journal (see p 919) provides data from Quebec that help us to understand why the folic acid concentration in enriched flour in the United States and Canada needs to be increased and why folic acid fortification should be rapidly implemented in countries not currently requiring fortification. In a carefully researched and analyzed study, De Wals and colleagues find that before folic acid flour fortification, the rate of neural tube defects was about 2.0 per 1000; after fortification, the rate dropped to about 1.25 per 1000. The rapid reduction in the rate of neural tube defects in Canada has also been documented by other studies in North America (Honein et al., 2001; Persad et al., 2002; Ray et al. 2002; Williams et al., 2002). The folic acid fortification program required in 1998 by the health and food authorities in the United States and Canada has improved the lives of hundreds of children who were born without neural tube defects they might have otherwise had. Not only have these North American programs been shown to be effective in preventing neural tube defects, but also they have been shown to increase serum folate levels enough to virtually eliminate folate deficiency anemia—a substantial benefit not anticipated in pre-fortification discussions (Lawrence et al., 1999). In addition, fortification reduced concentrations of homocysteine in the adult population (Jacques et al., 1999). Although we have yet to learn the effect of such reductions, reasonable projections by Wald and colleagues suggest that fortification may have prevented up to 25% of heart attacks and strokes (Wald et al., 2002). If the reductions in homocysteine prevent even 10% of heart attacks and strokes, mandatory folic acid fortification of flour and other grain products has prevented 10 times as many adults from dying from cardiovascular disease as it has prevented babies from having birth defects. There have been no adverse effects reported for millions of Canadians and Americans who have been eating folic acidfortified products. We can conclude that the current fortification in Canada and the United States is safe and has been good for both adults and children. The data in the DeWals et al. article and data from the China study (Berry et al., 1999) suggest that increasing the concentration of folic acid in enriched grain products will produce even greater benefits. There is no general agreement on the prevalence of non-folic acid-preventable neural tube defects. The data from the China study (Berry et al., 1999) showed that the prevalence of neural tube defects was 0.6 per 1000 pregnancies for women who consumed 400 g of synthetic folic acid in a vitamin pill. It is reasonable to assume that the prevalence of non-folic acid-preventable neural tube defects is no more than 0.5 per 1000 pregnancies. Wald and colleagues use the available evidence to describe a doseresponse curve between increased folic acid consumption and decreases in neural tube defects that suggests the rate of the non-folic acid-preventable neural tube defects is less than 0.5 per 1000 pregnancies (Wald et al., 2001). The post-fortification prevalence observed in Quebec is about 1.25 per 1000, which the China data suggest can be lowered to 0.5 per 1000. The data from China and Quebec thus suggest that the post-fortification prevalence rate of neural tube defects in North America remains about twice what it should be. Yes, we have reduced the size of the epidemic, but there is still an epidemic that needs to be fully controlled. No one should be surprised that the decrease in neural tube defects after fortification was not larger. There was general agreement before fortification that the concentration selected would likely fail to accomplish as much prevention as a greater concentration could have. The pre-
Full Text
Topics from this Paper
Rate Of Neural Tube Defects
Prevalence Of Neural Tube Defects
Neural Tube Defects
Folic Acid
Folic Acid Fortification
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
The Lancet Global Health
Jul 1, 2022
Genetics in Medicine
Dec 1, 2021
Journal of Epidemiology & Community Health
Feb 1, 1993
Congenital Anomalies
Apr 3, 2019
Acta Medica Philippina
Mar 30, 2022
Journal of pediatric neurology
Jan 1, 2014
Child's Nervous System
Oct 30, 2012
Birth Defects Research Part A: Clinical and Molecular Teratology
Jun 1, 2004
Cadernos De Saude Publica
Jan 1, 2013
The Journal of Pediatrics
Nov 1, 2020
British Journal of Nutrition
Dec 16, 2008
Obstetrical & Gynecological Survey
Dec 1, 2008
Public Health Reviews
May 31, 2010
Birth Defects Research Part A: Clinical and Molecular Teratology
Birth Defects Research Part A: Clinical and Molecular Teratology
Dec 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Dec 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016
Birth Defects Research Part A: Clinical and Molecular Teratology
Nov 1, 2016